Addendum: sartan treatment during pregnancy.
Alwan
Sura
S
Department of Medical Genetics, University of British Columbia, Vancouver, Canada. alwans@interchange.ubc.ca
Polifka
Janine E
JE
Friedman
Jan M
JM
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005313:Fetal Death / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D011247:Pregnancy; D013723:Teratogens / Q000633:toxicity
D047228:Angiotensin II Type 1 Receptor Blockers; D013723:Teratogens